ACET
Price
$0.90
Change
+$0.04 (+4.65%)
Updated
Dec 20, 04:59 PM (EDT)
79 days until earnings call
ITCI
Price
$83.46
Change
-$0.68 (-0.81%)
Updated
Dec 20, 04:59 PM (EDT)
65 days until earnings call
Ad is loading...

ACET vs ITCI

Header iconACET vs ITCI Comparison
Open Charts ACET vs ITCIBanner chart's image
Adicet Bio
Price$0.90
Change+$0.04 (+4.65%)
Volume$14.61K
CapitalizationN/A
Intra-Cellular Therapies
Price$83.46
Change-$0.68 (-0.81%)
Volume$16K
CapitalizationN/A
ACET vs ITCI Comparison Chart
Loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACET vs. ITCI commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACET is a Hold and ITCI is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ACET: $0.91 vs. ITCI: $83.45)
Brand notoriety: ACET: Not notable vs. ITCI: Notable
ACET represents the Biotechnology, while ITCI is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ACET: 102% vs. ITCI: 190%
Market capitalization -- ACET: $73.55M vs. ITCI: $6.7B
ACET [@Biotechnology] is valued at $73.55M. ITCI’s [@Pharmaceuticals: Other] market capitalization is $6.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $464.4B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.54B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACET’s FA Score shows that 2 FA rating(s) are green whileITCI’s FA Score has 1 green FA rating(s).

  • ACET’s FA Score: 2 green, 3 red.
  • ITCI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ACET and ITCI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACET’s TA Score shows that 3 TA indicator(s) are bullish while ITCI’s TA Score has 2 bullish TA indicator(s).

  • ACET’s TA Score: 3 bullish, 4 bearish.
  • ITCI’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, ACET is a better buy in the short-term than ITCI.

Price Growth

ACET (@Biotechnology) experienced а -5.68% price change this week, while ITCI (@Pharmaceuticals: Other) price change was +0.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.20%. For the same industry, the average monthly price growth was -1.27%, and the average quarterly price growth was +2.17%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.34%. For the same industry, the average monthly price growth was -0.19%, and the average quarterly price growth was -10.14%.

Reported Earning Dates

ACET is expected to report earnings on Mar 12, 2025.

ITCI is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-2.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Other (-1.34% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ITCI($6.7B) has a higher market cap than ACET($73.6M). ITCI YTD gains are higher at: 16.518 vs. ACET (-51.852). ACET has higher annual earnings (EBITDA): -111.35M vs. ITCI (-158.85M). ITCI has more cash in the bank: 498M vs. ACET (202M). ITCI has less debt than ACET: ITCI (16.9M) vs ACET (18.2M). ITCI has higher revenues than ACET: ITCI (462M) vs ACET (0).
ACETITCIACET / ITCI
Capitalization73.6M6.7B1%
EBITDA-111.35M-158.85M70%
Gain YTD-51.85216.518-314%
P/E RatioN/AN/A-
Revenue0462M-
Total Cash202M498M41%
Total Debt18.2M16.9M108%
FUNDAMENTALS RATINGS
ACET vs ITCI: Fundamental Ratings
ACET
ITCI
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
67
Overvalued
PROFIT vs RISK RATING
1..100
1007
SMR RATING
1..100
9792
PRICE GROWTH RATING
1..100
8748
P/E GROWTH RATING
1..100
22100
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACET's Valuation (33) in the Medical Distributors industry is somewhat better than the same rating for ITCI (67) in the Biotechnology industry. This means that ACET’s stock grew somewhat faster than ITCI’s over the last 12 months.

ITCI's Profit vs Risk Rating (7) in the Biotechnology industry is significantly better than the same rating for ACET (100) in the Medical Distributors industry. This means that ITCI’s stock grew significantly faster than ACET’s over the last 12 months.

ITCI's SMR Rating (92) in the Biotechnology industry is in the same range as ACET (97) in the Medical Distributors industry. This means that ITCI’s stock grew similarly to ACET’s over the last 12 months.

ITCI's Price Growth Rating (48) in the Biotechnology industry is somewhat better than the same rating for ACET (87) in the Medical Distributors industry. This means that ITCI’s stock grew somewhat faster than ACET’s over the last 12 months.

ACET's P/E Growth Rating (22) in the Medical Distributors industry is significantly better than the same rating for ITCI (100) in the Biotechnology industry. This means that ACET’s stock grew significantly faster than ITCI’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACETITCI
RSI
ODDS (%)
Bullish Trend 4 days ago
88%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
74%
Momentum
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 6 days ago
65%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
86%
Bullish Trend 4 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 15 days ago
82%
Bullish Trend 7 days ago
74%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 4 days ago
72%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
69%
Aroon
ODDS (%)
Bearish Trend 4 days ago
86%
Bearish Trend 4 days ago
75%
View a ticker or compare two or three
Ad is loading...
ACET
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ITCI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TPYP33.910.53
+1.59%
Tortoise North American Pipeline
IXN85.611.06
+1.25%
iShares Global Tech ETF
PSET72.320.71
+1.00%
Principal Quality ETF
TDSC24.750.23
+0.94%
Cabana Target Drawdown 10 ETF
HYUP41.960.19
+0.45%
Xtrackers High Beta High Yield Bond ETF

ACET and

Correlation & Price change

A.I.dvisor indicates that over the last year, ACET has been loosely correlated with OGI. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ACET jumps, then OGI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ACET
1D Price
Change %
ACET100%
+5.78%
OGI - ACET
41%
Loosely correlated
+6.85%
DVAX - ACET
39%
Loosely correlated
-0.31%
KYMR - ACET
38%
Loosely correlated
+3.88%
CRON - ACET
36%
Loosely correlated
+4.28%
PRTA - ACET
36%
Loosely correlated
-4.93%
More

ITCI and

Correlation & Price change

A.I.dvisor tells us that ITCI and ACET have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ITCI and ACET's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ITCI
1D Price
Change %
ITCI100%
-0.82%
ACET - ITCI
32%
Poorly correlated
+5.78%
AVDL - ITCI
29%
Poorly correlated
+1.98%
SXTC - ITCI
27%
Poorly correlated
-5.91%
SUPN - ITCI
25%
Poorly correlated
-0.95%
PRGO - ITCI
24%
Poorly correlated
+0.08%
More